Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis-Reference-Cited by-同舟云学术

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis

Published:2016-07-26 Issue:21 Volume:122 Page:3386-3393
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Carlsson Sigrid V.¹²³,de Carvalho Tiago M.⁴,Roobol Monique J.⁵,Hugosson Jonas³⁶,Auvinen Anssi⁷,Kwiatkowski Maciej⁸⁹,Villers Arnauld¹⁰,Zappa Marco¹¹,Nelen Vera¹²,Páez Alvaro¹³,Eastham James A.¹⁴,Lilja Hans¹⁴¹⁵¹⁶¹⁷¹⁸,de Koning Harry J.⁴,Vickers Andrew J.²,Heijnsdijk Eveline A. M.⁴

Affiliation:

1. Deptartment of Surgery; Memorial Sloan Kettering Cancer Center; New York New York

2. Department of Epidemiology and Biostatistics; Memorial Sloan Kettering Cancer Center; New York New York

3. Department of Urology; Sahlgrenska Academy at the University of Gothenburg; Gothenburg Sweden

4. Department of Public Health; Erasmus Medical Center; Rotterdam the Netherlands

5. Department of Urology; Erasmus Medical Center; Rotterdam the Netherlands

6. Sahlgrenska University Hospital; Sahlgrenska Academy at the University of Gothenburg; Gothenburg Sweden

7. School of Health Sciences; Tampere University; Tampere Finland

8. Department of Urology; Cantonal Hospital Aarau; Aarau Switzerland

9. Department of Urology; Academic Hospital Braunschweig; Brunswick Germany

10. Department of Urology; Lille University Hospital, University of Lille Nord de France; Lille France

11. Unit of Clinical and Descriptive Epidemiology; Institute for Cancer Research and Prevention-ISPO; Florence Italy

12. Provincial Institute for Hygiene; Antwerp Belgium

13. Department of Urology; Fuenlabrada University Hospital; Madrid Spain

14. Urology Service; Department of Surgery; Memorial Sloan Kettering Cancer Center; New York New York

15. Department of Laboratory Medicine; Memorial Sloan Kettering Cancer Center; New York New York

16. Genitourinary Oncology Service; Department of Medicine, Memorial Sloan Kettering Cancer Center; New York New York

17. Nuffield Department of Surgical Sciences; University of Oxford; Oxford United Kingdom

18. Department of Translational Medicine; Lund University; Malmo Sweden

Funder

AFA Insurance

Swedish Cancer Society

Swedish Prostate Cancer Foundation

Research Foundation

Department of Urology at Sahlgrenska University Hospital

Sweden America Foundation

Swedish Council for Working Life and Social Research

Swedish Society for Medical Research

National Institutes of Health/National Cancer Institute (NIH/NCI)

Sidney Kimmel Center for Prostate and Urologic Cancers

Prostate Cancer Foundation

NIH/NCI

National Institute for Health Research Oxford Biomedical Research Centre Program

TEKES, Finland

Fundacion Federico SA

Beckman Coulter

Dutch Cancer Society and the Netherlands Organization for Health Research and Development

Finnish Cancer Society and the Academy of Finland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30192/fullpdf

Reference32 articles.

1. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schroder;Lancet.,2014

2. Screening for prostate cancer: US Preventive Services Task Force recommendation statement;Moyer;Ann Intern Med.,2012

3. Quality-of-life effects of prostate-specific antigen screening;Heijnsdijk;N Engl J Med.,2012

4. Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review;Carlsson;J Clin Oncol.,2012

5. It ain't what you do, it's the way you do it: 5 golden rules for transforming prostate-specific antigen screening;Vickers;Eur Urol.,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam;European Urology;2024-01

2. Adherence to a risk‐adapted screening strategy for prostate cancer: First results of the PROBASE trial;International Journal of Cancer;2022-10-05

3. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future;Nature Reviews Urology;2022-08-16

4. Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial;Journal of Urology;2022-08

5. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission;European Urology;2021-03